Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much?
Heart failure (HF) is a major public health problem characterised by a high rate of hospitalisation and death. The risk is maximal for patients admitted with acute heart failure (AHF). New therapies with solid proof of mortality reduction in both groups of patients with reduced and preserved ejectio...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2022-12-01
|
| Series: | Romanian Journal of Cardiology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjc-2022-0035 |
| _version_ | 1811171406701920256 |
|---|---|
| author | Nechita Alexandru Cristian |
| author_facet | Nechita Alexandru Cristian |
| author_sort | Nechita Alexandru Cristian |
| collection | DOAJ |
| description | Heart failure (HF) is a major public health problem characterised by a high rate of hospitalisation and death. The risk is maximal for patients admitted with acute heart failure (AHF). New therapies with solid proof of mortality reduction in both groups of patients with reduced and preserved ejection fraction (EF) are now available (valsartan/sacubitril and SGLT2 inhibitors). |
| first_indexed | 2024-04-10T17:13:32Z |
| format | Article |
| id | doaj.art-fde1915ea3544a49a36b95efbef0cd5f |
| institution | Directory Open Access Journal |
| issn | 2734-6382 |
| language | English |
| last_indexed | 2024-04-10T17:13:32Z |
| publishDate | 2022-12-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Romanian Journal of Cardiology |
| spelling | doaj.art-fde1915ea3544a49a36b95efbef0cd5f2023-02-05T19:46:30ZengSciendoRomanian Journal of Cardiology2734-63822022-12-0132416717310.2478/rjc-2022-0035Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much?Nechita Alexandru Cristian0“Sf. Pantelimon” Emergency Hospital, Bucharest, RomaniaHeart failure (HF) is a major public health problem characterised by a high rate of hospitalisation and death. The risk is maximal for patients admitted with acute heart failure (AHF). New therapies with solid proof of mortality reduction in both groups of patients with reduced and preserved ejection fraction (EF) are now available (valsartan/sacubitril and SGLT2 inhibitors).https://doi.org/10.2478/rjc-2022-0035heart failurevalsartan/sacubitrilsglt2 inhibitorsinsuficiență cardiacăvalsartan/sacubitrilinhibitori sglt2 |
| spellingShingle | Nechita Alexandru Cristian Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much? Romanian Journal of Cardiology heart failure valsartan/sacubitril sglt2 inhibitors insuficiență cardiacă valsartan/sacubitril inhibitori sglt2 |
| title | Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much? |
| title_full | Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much? |
| title_fullStr | Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much? |
| title_full_unstemmed | Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much? |
| title_short | Earlier is Better. New Options for Acute Heart Failure: When, Who, How Much? |
| title_sort | earlier is better new options for acute heart failure when who how much |
| topic | heart failure valsartan/sacubitril sglt2 inhibitors insuficiență cardiacă valsartan/sacubitril inhibitori sglt2 |
| url | https://doi.org/10.2478/rjc-2022-0035 |
| work_keys_str_mv | AT nechitaalexandrucristian earlierisbetternewoptionsforacuteheartfailurewhenwhohowmuch |